Abstract:Highlights • Reported chitosan-graphene oxide-based thermosensitive in situ hydrogel for intranasal application. • Thermosensitive intranasal hydrogel offers the sustained release of rasagiline mesylate. • Graphene oxide reduces gelation time and temperature while enhancing the mechanical strength of hydrogel. • The designed hydrogel holds promising potential for delivering centrally-acting drugs. Intranasal administration of a drug offers a way to bypass the blood-brain barrier, allowing for an increased drug concentration in the brain and improved bioavailability. In this context, the preference for polymeric thermoresponsive intranasal hydrogels has been widely documented. Here, there is a need to enhance the physical properties of the hydrogel and improve control over the release of the drug. In this work, we propose the incorporation of graphene oxide (GO) into a thermosensitive in situ hydrogel (RM@CS/B-GP-GO) based on chitosan (CS) and beta-glycerophosphate (B-GP) for intranasal delivery of rasagiline mesylate (RM). The prepared in situ hydrogel formulations were characterized using gelation temperature, gelation time, swelling, porosity, gel strength, mucoadhesive strength, pH, morphological features, spectral analysis, drug release, permeation study, and so on. In this work, the incorporation of GO showed a significant concentration-dependent effect on the properties of the thermosensitive CS hydrogel. In brief, the addition of GO in RM@CS/B-GP decreased the gelation time, porosity, and swelling of the hydrogel. Additionally, CS-hydrogel strength increased with higher concentrations of GO. The RM@CS/B-GP-GO hydrogel (1 mg/mL of GO) showed the customized release of RM almost 68.41 ± 2.01 % in 8 h than the RM@CS/B-GP hydrogel (log p < 0.05). Based on these findings, the physical and mechanical properties of the RM@CS/B-GP-GO thermosensitive hydrogel were improved by the addition of optimized concentration GO. Moreover, RM@CS/B-GP-GO hydrogel shows good biocompatibility with nasal mucosa. Overall, the design of RM@CS/B-GP-GO can open new options for the delivery of RM through the nasal route. Graphical abstract Download : Download high-res image (237KB) Download : Download full-size image

A novel Thermo-responsive hydrogel system (THS) loaded with the active ingredient of Gardenia jasminoides J. Ellis exhibits anti-depressant effects in vivo via intranasal administration

Design, characterization of Resveratrol-Thermosensitive Hydrogel System (Res-THS) and evaluation of its anti-depressant effect via intranasal administration

Thermosensitive hydrogel designed for improving the antidepressant activities of genipin via intranasal delivery

Anti-depressant effect of curcumin-loaded guanidine-chitosan thermo-sensitive hydrogel by nasal delivery

Intranasal co-delivery of berberine and evodiamine by self-assembled thermosensitive in-situ hydrogels for improving depressive disorder

Alginate nanogels-based thermosensitive hydrogel to improve antidepressant-like effects of albiflorin via intranasal delivery

Intranasal delivery of icariin via a nanogel-thermoresponsive hydrogel compound system to improve its antidepressant-like activity

2,3,5,4′-Tetrahydroxystilbene-2-o-beta-d-glucoside Reverses Stress-Induced Depression Via Inflammatory and Oxidative Stress Pathways

Establishment and Validation of a Transdermal Drug Delivery System for the Anti-Depressant Drug Citalopram Hydrobromide

Network pharmacology screening, in vitro and in vivo evaluation of antianxiety and antidepressant drug-food analogue

Production, Characterization, and In Vitro and In Vivo Studies of Nanoemulsions Containing St. John's Wort Plant Constituents and Their Potential for the Treatment of Depression

Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients

Chitosan Nanoparticles Embedded in In Situ Gel for Nasal Delivery of Imipramine Hydrochloride: Short-Term Stage Development and Controlled Release Evaluation

Formulation and Evaluation of In Situ Gelling Systems for Intranasal Administration of Gastrodin

Chitosan Hydrogel Delivery System Containing Herbal Compound Functions as a Potential Antineuroinflammatory Agent

A Self-microemulsifying Drug Delivery System (SMEDDS) for a Novel Medicative Compound Against Depression: a Preparation and Bioavailability Study in Rats

Brain Targeting of Venlafaxine via Intranasal Transbilosomes Thermogel for Improved Management of Depressive Disorder

Formulation of Intranasal Mucoadhesive Thermotriggered In Situ Gel Containing Mirtazapine as an Antidepressant Drug

One Water-Soluble Polysaccharide from Ginkgo Biloba Leaves with Antidepressant Activities Via Modulation of the Gut Microbiome.

Synthesis of chitosan-graphene oxide thermosensitive in situ hydrogel for nasal delivery of rasagiline mesylate: In-vitro-ex vivo characterization

Synthesis and biological evaluation of novel naphthalene compounds as potential antidepressant agents